BAG3 gene silencing sensitizes leukemic cells to Bortezomib-induced apoptosis

FEBS Letters

Volumn 583, Issue 2, 2009, Pages 401-406

  Liu, Peng ^a   Xu, Bei ^a   Li, Jianyong ^a   Lu, Hua ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; BAG3; Bortezomib; Leukemia; Proteasome inhibitor

Indexed keywords

ALPHA TUBULIN; BORTEZOMIB; GENE PRODUCT; I KAPPA B; PROTEIN BAG3; PROTEIN P21; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BAG3 GENE; CANCER MODEL; CONTROLLED STUDY; DRUG POTENCY; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMIA CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SENSITIZATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BORONIC ACIDS; CASPASE 3; CYSTEINE PROTEINASE INHIBITORS; DRUG RESISTANCE, NEOPLASM; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; LEUKEMIA; MICE; PROTEASOME ENDOPEPTIDASE COMPLEX; PYRAZINES; RNA, SMALL INTERFERING;

MUS MUSCULUS;

EID: 58149494120     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.12.032     Document Type: Article

References (35)

1. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell 79 (1994) 13-21
2. Adams J. Proteasome inhibition in cancer: development of PS-341. Semin. Oncol. 28 (2001) 613-619
3. Adams J. Development of the proteasome inhibitor PS-341. Oncologist 7 (2002) 9-16
4. Adams J. The development of proteasome inhibitors as anticancer drugs. Cancer Cell 5 (2004) 417-421
5. Rajkumar S.V., Richardson P.G., Hideshima T., and Anderson K.C. Proteasome inhibition as a novel therapeutic target in human cancer. J Clin Oncol 23 (2005) 630-639
6. Orlowski R.Z., and Kuhn D.J. Proteasome inhibitors in cancer therapy: lessons from the first decade. Clin. Cancer Res. 14 (2008) 1649-1657
7. Orlowski R.Z., Voorhees P.M., Garcia R.A., Hall M.D., Kudrik F.J., Allred T., Johri A.R., Jones P.E., Ivanova A., Van Deventer H.W., Gabriel D.A., Shea T.C., Mitchell B.S., Adams J., Esseltine D.L., Trehu E.G., Green M., Lehman M.J., Natoli S., Collins J.M., Lindley C.M., and Dees E.C. Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies. Blood 105 (2005) 3058-3065
8. Cortes J., Thomas D., Koller C., Giles F., Estey E., Faderl S., Garcia-Manero G., McConkey D., Ruiz S.L., Guerciolini R., Wright J., and Kantarjian H. Phase I study of bortezomib in refractory or relapsed acute leukemias. Clin. Cancer Res. 10 (2004) 3371-3376
9. Doong H., Vrailas A., and Kohn E.C. What's in the 'BAG'?-A functional domain analysis of the BAG-family proteins. Cancer Lett. 188 (2002) 25-32
10. Doong H., Price J., Kim Y.S., Gasbarre C., Probst J., Liotta L.A., Blanchette J., Rizzo K., and Kohn E. CAIR-1/BAG-3 forms an EGF-regulated ternary complex with phospholipase C-gamma and Hsp70/Hsc70. Oncogene 19 (2000) 4385-4395
11. Lee J.H., Takahashi T., Yasuhara N., Inazawa J., Kamada S., and Tsujimoto Y. Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death. Oncogene 18 (1999) 6183-6190
12. Antoku K., Maser R.S., Scully Jr. W.J., Delach S.M., and Johnson D.E. Isolation of Bcl-2 binding proteins that exhibit homology with BAG-1 and suppressor of death domains protein. Biochem. Biophys. Res. Commun. 286 (2001) 1003-1010
13. Takayama S., and Reed J.C. Molecular chaperone targeting and regulation by BAG family proteins. Nat. Cell Biol. 3 (2001) E237-241
14. Takayama S., Xie Z., and Reed J.C. An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators. J. Biol. Chem. 274 (1999) 781-786
15. Romano M.F., Festa M., Pagliuca G., Lerose R., Bisogni R., Chiurazzi F., Storti G., Volpe S., Venuta S., Turco M.C., and Leone A. BAG3 protein controls B-chronic lymphocytic leukaemia cell apoptosis. Cell Death Differ. 10 (2003) 383-385
16. Romano M.F., Festa M., Petrella A., Rosati A., Pascale M., Bisogni R., Poggi V., Kohn E.C., Venuta S., Turco M.C., and Leone A. BAG3 protein regulates cell survival in childhood acute lymphoblastic leukemia cells. Cancer Biol. Ther. 2 (2003) 508-510
17. Bonelli P., Petrella A., Rosati A., Romano M.F., Lerose R., Pagliuca M.G., Amelio T., Festa M., Martire G., Venuta S., Turco M.C., and Leone A. BAG3 protein regulates stress-induced apoptosis in normal and neoplastic leukocytes. Leukemia 18 (2004) 358-360
18. Belmokhtar C.A., Hillion J., and Ségal-Bendirdjian E. Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms. Oncogene 20 (2001) 3354-3362
19. Colado E., Alvarez-Fernández S., Maiso P., Martín-Sánchez J., Vidriales M.B., Garayoa M., Ocio E.M., Montero J.C., Pandiella A., and San Miguel J.F. The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype. Haematologica 93 (2008) 57-66
20. Shen L., Au W.Y., Guo T., Wong K.Y., Wong M.L., Tsuchiyama J., Yuen P.W., Kwong Y.L., Liang R.H., and Srivastava G. Proteasome inhibitor bortezomib-induced apoptosis in natural killer (NK)-cell leukemia and lymphoma: an in vitro and in vivo preclinical evaluation. Blood 110 (2007) 469-470
21. Satou Y., Nosaka K., Koya Y., Yasunaga J.I., Toyokuni S., and Matsuoka M. Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro. Leukemia 18 (2004) 1357-1363
22. LeBlanc R., Catley L.P., Hideshima T., Lentzsch S., Mitsiades C.S., Mitsiades N., Neuberg D., Goloubeva O., Pien C.S., Adams J., Gupta D., Richardson P.G., Munshi N.C., and Anderson K.C. Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model. Cancer Res. 62 (2002) 4996-5000
23. Adams J., Palombella V.J., Sausville E.A., Johnson J., Destree A., Lazarus D.D., Maas J., Pien C.S., Prakash S., and Elliott P.J. Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res. 59 (1999) 2615-2622
24. Koepp D.M., Harper J.W., and Elledge S.J. How the cyclin became a cyclin: regulated proteolysis in the cell cycle. Cell 97 (1999) 431-434
25. Karin M., Yamamoto Y., and Wang Q.M. The IKK NF-kappa B system: a treasure trove for drug development. Nat. Rev. Drug Discov. 3 (2004) 17-26
26. Ciechanover A. The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J. 17 (1998) 7151-7160
27. Pagano M., Tam S.W., Theodoras A.M., Beer-Romero P., Del Sal G., Chau V., Yew P.R., Draetta G.F., and Rolfe M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269 (1995) 682-685
28. Sulahian R., Sikder D., Johnston S.A., and Kodadek T. The proteasomal ATPase complex is required for stress-induced transcription in yeast. Nucleic Acids Res. 34 (2006) 1351-1357
29. Adams J. The proteasome: a suitable antineoplastic target. Nat. Rev. Cancer 4 (2004) 349-360
30. Takayama S., Bimston D.N., Matsuzawa S., Freeman B.C., Aime-Sempe C., Xie Z., Morimoto R.I., and Reed J.C. BAG-1 modulates the chaperone activity of Hsp70/Hsc70. EMBO J. 16 (1997) 4887-4896
31. Rosati A., Ammirante M., Gentilella A., Basile A., Festa M., Pascale M., Marzullo L., Belisario M.A., Tosco A., Franceschelli S., Moltedo O., Pagliuca G., Lerose R., and Turco M.C. Apoptosis inhibition in cancer cells: a novel molecular pathway that involves BAG3 protein. Int. J. Biochem. Cell Biol. 39 (2007) 1337-1342
32. Homma S., Iwasaki M., Shelton G.D., Engvall E., Reed J.C., and Takayama S. BAG3 deficiency results in fulminant myopathy and early lethality. Am. J. Pathol. 169 (2006) 761-773
33. Chiappetta G., Ammirante M., Basile A., Rosati A., Festa M., Monaco M., Vuttariello E., Pasquinelli R., Arra C., Zerilli M., Todaro M., Stassi G., Pezzullo L., Gentilella A., Tosco A., Pascale M., Marzullo L., Belisario M.A., Turco M.C., and Leone A. The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J. Clin. Endocrinol. Metab. 92 (2007) 1159-1163
34. Wang H.Q., Liu H.M., Zhang H.Y., Guan Y., and Du Z.X. Transcriptional upregulation of BAG3 upon proteasome inhibition. Biochem. Biophys. Res. Commun. 365 (2008) 381-385
35. Sarközi R., Perco P., Hochegger K., Enrich J., Wiesinger M., Pirklbauer M., Eder S., Rudnicki M., Rosenkranz A.R., Mayer B., Mayer G., and Schramek H. Bortezomib-induced survival signals and genes in human proximal tubular cells. J. Pharmacol. Exp. Ther. 327 (2008) 645-656